S. R. Khan

Novel, potent, orally bioavailable and selective mycobacterial ATP synthase inhibitors that demonstrated activity against both replicating and non-replicating M. tuberculosis.

A. Saxena, M. Y. Krishnan, S. Jaiswal, 2015, Bioorganic & medicinal chemistry.

Biological evaluation of novel substituted chloroquinolines targeting mycobacterial ATP synthase.

A. Saxena, Md. Sohail Akhtar, M. Y. Krishnan, 2013, International journal of antimicrobial agents.

Coupling reporter expression to respiration detects active as well as dormant mycobacteria in vitro and in mouse tissues.

Md. Sohail Akhtar, U. Venugopal, M. Y. Krishnan, 2014, International journal of mycobacteriology.

Mycobacterium tuberculosis persistence in various adipose depots of infected mice and the effect of anti-tubercular therapy.

Md. Sohail Akhtar, Muheeb Beg, A. Gaikwad, 2014, Microbes and infection.

Isocitrate lyase of Mycobacterium tuberculosis is inhibited by quercetin through binding at N-terminus.

Md. Sohail Akhtar, A. Singh, M. Siddiqi, 2015, International journal of biological macromolecules.

Effect of various drugs on differentially detectable persisters of Mycobacterium tuberculosis generated by long-term lipid diet.

Suman Bharti, R. Maurya, U. Venugopal, 2019, Tuberculosis.

Alternate pathway to ascorbate induced inhibition of Mycobacterium tuberculosis.

Md. Sohail Akhtar, T. Tripathi, R. Shukla, 2018, Tuberculosis.